1. Home
  2. PAYO vs AVDL Comparison

PAYO vs AVDL Comparison

Compare PAYO & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAYO
  • AVDL
  • Stock Information
  • Founded
  • PAYO 2005
  • AVDL 2015
  • Country
  • PAYO United States
  • AVDL Ireland
  • Employees
  • PAYO N/A
  • AVDL N/A
  • Industry
  • PAYO EDP Services
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAYO Technology
  • AVDL Health Care
  • Exchange
  • PAYO Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • PAYO 2.1B
  • AVDL 1.8B
  • IPO Year
  • PAYO N/A
  • AVDL 1996
  • Fundamental
  • Price
  • PAYO $5.25
  • AVDL $18.85
  • Analyst Decision
  • PAYO Strong Buy
  • AVDL Buy
  • Analyst Count
  • PAYO 8
  • AVDL 9
  • Target Price
  • PAYO $10.06
  • AVDL $17.56
  • AVG Volume (30 Days)
  • PAYO 2.7M
  • AVDL 4.7M
  • Earning Date
  • PAYO 11-05-2025
  • AVDL 11-04-2025
  • Dividend Yield
  • PAYO N/A
  • AVDL N/A
  • EPS Growth
  • PAYO N/A
  • AVDL N/A
  • EPS
  • PAYO 0.18
  • AVDL N/A
  • Revenue
  • PAYO $1,039,820,000.00
  • AVDL $248,517,000.00
  • Revenue This Year
  • PAYO $9.64
  • AVDL $64.21
  • Revenue Next Year
  • PAYO $7.37
  • AVDL $30.80
  • P/E Ratio
  • PAYO $29.58
  • AVDL N/A
  • Revenue Growth
  • PAYO 10.58
  • AVDL 79.88
  • 52 Week Low
  • PAYO $4.92
  • AVDL $6.38
  • 52 Week High
  • PAYO $11.29
  • AVDL $19.06
  • Technical
  • Relative Strength Index (RSI)
  • PAYO 28.61
  • AVDL 77.52
  • Support Level
  • PAYO $4.92
  • AVDL $18.74
  • Resistance Level
  • PAYO $5.87
  • AVDL $19.00
  • Average True Range (ATR)
  • PAYO 0.20
  • AVDL 0.40
  • MACD
  • PAYO -0.04
  • AVDL 0.06
  • Stochastic Oscillator
  • PAYO 25.19
  • AVDL 94.65

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: